Global Aortic Stent Grafts Market

Aortic Stent Grafts Market Size, Share, Growth Analysis, By Product Type(Abdominal Aortic Stent Graft, and Thoracic Aortic Stent Graft.), By End User(Hospitals, and Ambulatory Surgical Centers/Outpatient Surgical Centers.) - Industry Forecast 2024-2031


Report ID: SQMIG35B2078 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 61 | Figures: 77

Aortic Stent Grafts Market Insights

Global Aortic Stent Grafts Market was valued at USD 2.55 billion in 2022 and is expected to rise from USD 2.65 billion in 2023 to reach USD 3.63 billion by the end of 2031, by rising at a CAGR of 4% during the forecast period, (2024-2031).

An aortic stent is a metal skeleton enclosed in a fabric graft. In order to stop the aneurysm's blood supply from continuing, the graft usually works by applying pressure to the sections of the artery above and below the aneurysm. The stent is inserted into the aorta and forms a secure passageway for blood, thus, allowing the aneurysm to contract.

One of the key reasons influencing the growth of the global aortic stent graft market is the rising prevalence of aortic aneurysm among patients worldwide. The increase in demand for repairing thoracic and abdominal aneurysm is a result of the rise in cardiovascular diseases (CVDs), and the longer average life expectancy of people. The market is also driven by customers choosing endovascular repair over open surgical repair and by the rising preference for minimally invasive surgeries because of their reduced discomfort and quick recovery times. Additionally, the market for aortic stent grafts benefits from urbanization, increase in R&D activities, improved healthcare infrastructure, and unhealthy lifestyles of people. Additionally, the rise in investments on research and development and clinical trials on improving aortic stent graft designs are likely to create lucrative growth opportunities for market participants during the projected period.

On the other hand, the lack of awareness about new EVAR treatment as well as the danger of endoleaks and other problems associated with the use of aortic stent grafts may pose hindrance to the overall market expansion. The market for aortic stent grafts may also face certain challenges due to a shortage of skilled medical personnel in underdeveloped regions.

US Aortic Stent Grafts Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Aortic Stent Grafts Market was valued at USD 2.55 billion in 2022 and is expected to rise from USD 2.65 billion in 2023 to reach USD 3.63 billion by the end of 2031, by rising at a CAGR of 4% during the forecast period, (2024-2031).

The competitive landscape for the aortic stent grafts market is fragmented owing to the presence of multiple vendors. Most players are making heavy investments on R&D, and new market initiatives to gain a competitive edge and attract high revenues. Other vendors are focusing on increasing their presence, production sites and facilities, production capacities, company strengths and weaknesses, and on new product launches to ensure their brand name stays amongst the top competitors. 'Medtronic Plc', 'Cook Medical Inc.', 'Endologix Inc.', 'W.L. Gore & Associates Inc.', 'Terumo Corporation', 'Lombard Medical Technologies', 'MicroPort Scientific Corporation', 'Merit Medical Systems Inc.', 'JOTEC GmbH', 'CryoLife Inc.', 'Lifetech Scientific (Shenzhen) Co. Ltd.', 'Becton, Dickinson and Company', 'Endospan Ltd.', 'Cardinal Health Inc.', 'MicroVention Inc.', 'Aptus Endosystems Inc.', 'Altura Medical Inc.', 'Penumbra Inc.', 'Biomerics LLC', 'Lombardi SA', 'In November 2023, TekniPlex Healthcare signed a definitive purchase agreement to acquire Seisa Medical, a full solution, complex manufacturing partner, and leader in AAA stent manufacturing. ', 'In September 2022, Getinge AB reported a partnership with Medtronic plc for the Radiant stent, the first covered stent indicated for chimney endovascular aneurysm repair (ChEVAR). This new balloon-expandable stent graft for renal arteries obtained CE mark approval on Sept. 20.'

The market for aortic stent grafts is anticipated to grow during the forecast period due to factors such as the adoption of endovascular repair over open surgical repair, growing life expectancy rate, the increasing use of minimally invasive surgeries, surge in number of clinical trials, and FDA approvals for the development of better aortic stent graft designs.

The market for aortic aneurysm stent grafts is anticipated to grow rapidly as a result of an ageing population and an increase in patients with aortic aneurysms, increased regulatory approvals, and quickening technological development efforts. The market will expand from 2023 to 2030 due to a rise in the prevalence of cardiac disorders and rising consumer awareness of stents and graph devices.

The market for aortic aneurysm stent grafts is anticipated to be dominated by North America. This is attributable to the rising aortic aneurysm cases, technological improvements, and robust financial incentives in the United States and Canada. Additionally, the increasing use of aortic aneurysm stent grafts in the nation will increase demand for therapies that incorporate them, thus, fostering a favourable environment for the expansion of the North American aortic aneurysm stent graft market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Aortic Stent Grafts Market

Product ID: SQMIG35B2078

$5,300
BUY NOW GET FREE SAMPLE